Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Observational, Multivariate Study to Evaluate the Best Predictor of Ovarian Response, Between AMH Measured With Fully Automated Assay and AFC

NCT04168892 is registered in ClinicalTrials.gov with Andros Day Surgery Clinic as lead sponsor.

NCT NCT04168892
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04168892 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Observational, Multivariate Study to Evaluate the Best Predictor of Ovarian Response, Between AMH Measured With Fully Automated Assay and AFC
Lead sponsor
Andros Day Surgery Clinic
Phase
Observational
Overall status
Completed
Start date
September 20, 2019
Completion date
January 31, 2023
Enrollment
160 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian response